Back to Journals » Drug Design, Development and Therapy » Volume 14

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study

Total article views   Abstract views HTML views PDF downloads Totals
2,136 Dovepress* 1,723 234+ 456 1,957
PubMed Central* 0 179 71 179
Totals 1,723 413 527 2,136
*Since 8 December 2020
+Since July 2016

View citations on PubMed Central and Google Scholar